Participant flow

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide · Source last updated 2020-03-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Patients that received a stem cell transplant from a haploidentical donor.

   id

   FG000

   title

   Haplo Arm

2. description

   Patients that received a transplant from a 1 antigen mismatched related or unrelated donor

   id

   FG001

   title

   1AgMM Related/Unrelated Donors

3. description

   Patients that received a transplant from a matched unrelated donor

   id

   FG002

   title

   MUD Donor

4. description

   Patients receiving a second transplant

   id

   FG003

   title

   Second Transplant

5. description

   Patients with the diagnosis of Myelofibrosis

   id

   FG004

   title

   Myelofibrosis

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         4

      2. group Id

         FG001

         num Subjects

         5

      3. group Id

         FG002

         num Subjects

         1

      4. group Id

         FG003

         num Subjects

         0

      5. group Id

         FG004

         num Subjects

         0

      type

      Lost to Follow-up

   2. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      4. group Id

         FG003

         num Subjects

         0

      5. group Id

         FG004

         num Subjects

         0

      type

      Withdrawal by Subject

   3. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      4. group Id

         FG003

         num Subjects

         6

      5. group Id

         FG004

         num Subjects

         3

      type

      Physician Decision

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         89

      2. group Id

         FG001

         num Subjects

         56

      3. group Id

         FG002

         num Subjects

         22

      4. group Id

         FG003

         num Subjects

         6

      5. group Id

         FG004

         num Subjects

         3

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         84

      2. group Id

         FG001

         num Subjects

         51

      3. group Id

         FG002

         num Subjects

         21

      4. group Id

         FG003

         num Subjects

         0

      5. group Id

         FG004

         num Subjects

         0

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         5

      2. group Id

         FG001

         num Subjects

         5

      3. group Id

         FG002

         num Subjects

         1

      4. group Id

         FG003

         num Subjects

         6

      5. group Id

         FG004

         num Subjects

         3

      type

      NOT COMPLETED

   title

   Overall Study

pre Assignment Details

Additional arm elderly patients did not accrue any participants so therefore was excluded from summary.

recruitment Details

Patients were enrolled during the period from January 2010 through August 2014 and were assigned to the HAPLO arm or the 9/10 MUD arm based on donor availability and physician preference. The 3 arms received identical melphalan-based conditioning chemotherapy and GVHD prophylaxis

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice